10058-F4
CAS No. 403811-55-2
10058-F4 ( 10058-F4 | 10058F4 | 10058 F4 )
产品货号. M14382 CAS No. 403811-55-2
10058-F4 是一种特异性 c-Myc 抑制剂,可破坏 c-Myc 和 Max 之间的关联。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥311 | 有现货 |
|
| 10MG | ¥549 | 有现货 |
|
| 25MG | ¥908 | 有现货 |
|
| 50MG | ¥1544 | 有现货 |
|
| 100MG | ¥2223 | 有现货 |
|
| 500MG | ¥5247 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥307 | 有现货 |
|
生物学信息
-
产品名称10058-F4
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述10058-F4 是一种特异性 c-Myc 抑制剂,可破坏 c-Myc 和 Max 之间的关联。
-
产品描述10058-F4 is a specific c-Myc inhibitor that disrupts the association between the c-Myc and Max, inhibits HL60 cell growth with IC50 of 51 uM; arrests AML cells at G0/G1 phase, downregulates c-Myc expression and upregulates CDK inhibitors p21 and p27; induces apoptosis through activation of mitochondrial pathway shown by downregulation of Bcl-2, upregulation of Bax, release of cytoplasmic cytochrome C, and cleavage of caspase 3, 7, and 9; also induces myeloid differentiation.
-
体外实验——
-
体内实验——
-
同义词10058-F4 | 10058F4 | 10058 F4
-
通路Cell Cycle/DNA Damage
-
靶点c-Myc
-
受体c-Myc-MAX
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number403811-55-2
-
分子量249.3518
-
分子式C12H11NOS2
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 41 mg/mL
-
SMILESO=C1NC(S/C1=C/C2=CC=C(CC)C=C2)=S
-
化学全称4-Thiazolidinone, 5-[(4-ethylphenyl)methylene]-2-thioxo-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Huang MJ, et al. Exp Hematol. 2006 Nov;34(11):1480-9.
2. Lin CP, et al. Anticancer Drugs. 2007 Feb;18(2):161-70.
3. Wang H, et al. Mol Cancer Ther. 2007 Sep;6(9):2399-408.
4. Guo J, et al. Cancer Chemother Pharmacol. 2009 Mar;63(4):615-25.
021-51111890
购物车()
sales@molnova.cn

